Rapport Therapeutics, Inc. Common Stock (RAPP) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Rapport Therapeutics, Inc. Common Stock (RAPP) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

RAPP Income Statement

Rapport Therapeutics, Inc. Common Stock (RAPP) annual income statement — 4-year revenue, gross profit & net income history

Annual Quarterly

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23

Sales/Revenue	0	20M	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	0	0	0	0	0	0	0	0	0	0	76K
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	20M	0	0	0	0	0	0	0	0	-76K
Gross Margin %	-	100%	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-	-	-	-	-	-	100%	-	-	-	-
Operating Expenses	60.81M	44.22M	38.51M	29.99M	29.5M	27.11M	23.52M	21.64M	20.8M	17.09M	14.72M
OpEx % of Revenue	-	221.07%	-	-	-	-	-	-	-	-	-
Selling, General & Admin	9.39M	11.5M	8.25M	7.71M	6.82M	7.54M	6.32M	6.1M	5.11M	4.59M	2.92M
SG&A % of Revenue	-	57.49%	-	-	-	-	-	-	-	-	-
Research & Development	51.41M	32.72M	30.26M	22.28M	22.68M	19.57M	17.2M	15.54M	15.69M	12.5M	11.8M
R&D % of Revenue	-	163.58%	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0	0
Operating Income	-60.81M	-24.21M	-38.51M	-29.99M	-29.5M	-27.11M	-23.52M	-21.64M	-20.8M	-17.09M	-14.79M
Operating Margin %	-	-121.08%	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-106.15%	10.67%	-63.72%	-38.57%	-41.81%	-58.58%	-58.99%	-	-	-	-
EBITDA	-60.37M	-23.99M	-38.24M	-29.73M	-29.24M	-26.86M	-23.26M	-21.42M	-20.59M	-16.94M	-14.74M
EBITDA Margin %	-	-119.94%	-	-	-	-	-	-	-	-	-
EBITDA Growth %	-106.43%	10.71%	-64.41%	-38.79%	-42.02%	-58.56%	-57.8%	-	-	-	-
D&A (Non-Cash Add-back)	439K	227K	265K	256K	252K	244K	260K	219K	208K	152K	53K
EBIT	-56.62M	-24.21M	-38.51M	-29.99M	-29.5M	-27.11M	-23.52M	-21.64M	-20.8M	-17.09M	-13.39M
Net Interest Income	4.19M	4.36M	4.75M	3.06M	2.76M	3.04M	3.54M	4.1M	2.68M	1.81M	1.38M
Interest Income	4.19M	4.36M	4.75M	3.06M	2.76M	3.04M	3.54M	4.1M	2.68M	1.81M	1.38M
Interest Expense	0	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	4.19M	4.36M	4.75M	3.06M	2.76M	3.04M	3.54M	4.1M	2.68M	-5.58M	1.28M
Pretax Income	-56.62M	-19.86M	-33.76M	-26.93M	-26.73M	-24.06M	-19.98M	-17.54M	-18.12M	-22.67M	-13.51M
Pretax Margin %	-	-99.28%	-	-	-	-	-	-	-	-	-
Income Tax	0	0	0	0	0	0	0	0	0	0	6K
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	-0.04%
Net Income	-56.62M	-19.86M	-33.76M	-26.93M	-26.73M	-24.06M	-19.98M	-17.54M	-18.12M	-22.67M	-13.52M
Net Margin %	-	-99.28%	-	-	-	-	-	-	-	-	-
Net Income Growth %	-111.79%	17.48%	-68.98%	-53.53%	-47.52%	-6.15%	-47.79%	-	-	-	-
Net Income (Continuing)	-56.62M	-19.86M	-33.76M	-26.93M	-26.73M	-24.06M	-19.98M	-17.54M	-18.12M	-22.67M	-13.52M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-1.19	-0.42	-0.72	-0.71	-0.75	-0.68	-0.57	-0.50	-0.50	-0.12	-0.07
EPS Growth %	-58.67%	38.24%	-26.32%	-42%	-50%	-466.67%	-662.03%	-	-	-	-
EPS (Basic)	-1.19	-0.42	-0.72	-0.71	-0.75	-0.68	-0.57	-0.50	-0.50	-0.12	-0.07
Diluted Shares Outstanding	47.47M	47.24M	46.98M	37.93M	35.44M	19.29M	19.29M	19.17M	20.12M	19.46M	18.08M
Basic Shares Outstanding	47.47M	47.24M	46.98M	37.93M	35.44M	19.29M	19.29M	19.17M	20.12M	19.46M	18.08M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-